Riley Antony A's Form 4 filing
Forte Biosciences, Inc. (FBRX) · filed Sep 7, 2021
- Accession no.
- 0000899243-21-035246
- Filed
- Sep 7, 2021
- Trade date
- Sep 7, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $106.1K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Riley Antony ACIK 0001339375 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2021 | Common Stock | SSaleDisposed | −21,484 | $4.24 | −$91,092.16 | 14,581 | Direct | |
| Sep 7, 2021 | Common Stock | SSaleDisposed | −3,516 | $4.27 | −$15,013.32 | 11,065 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.